Crossing the borders of innovationBasing clinical trials on sound mechanistic and scientific rationale. Combating Pan-Cancer with PrecisionSaving Lives of Patients Who Exhausted Treatment Options and Improving Clinical BenefitsCancer Patients are fighting for their lives...we will fight with themImagining a world without cancer. Apollomics is an innovative biopharmaceutical company committed to the discovery and development of oncology combination therapies. Pipeline Science Events Our Vision To become a global leader in the development of novel medicines for cancer patients. Learn More Recent News March 3, 2021 APOLLOMICS, INC ANNOUNCES SUCCESSFUL ENROLLMENT OF FIRST PATIENT INTO PHASE 1 CLINICAL TRIAL OF APL-106 (UPROLESELAN INJECTION) IN CHINA February 11, 2021 Apollomics, Inc. Licenses a Targeted, Active Checkpoint Control Immunotherapy for Greater China and South Africa More News
